S. Oudard Et Al. , "IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL," 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.23, Vienna, Austria, pp.307-308, 2012
Oudard, S. Et Al. 2012. IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL. 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Vienna, Austria), 307-308.
Oudard, S., de Bono, J. S., Ozguroglu, M., Hansen, S., Machiels, J., Kocak, I., ... Gravis, G.(2012). IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL . 37th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.307-308). Vienna, Austria
Oudard, S. Et Al. "IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL," 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 2012
Oudard, S. Et Al. "IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, pp.307-308, 2012
Oudard, S. Et Al. (2012) . "IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, pp.307-308.
@conferencepaper{conferencepaper, author={S. Oudard Et Al. }, title={IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL}, congress name={37th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Vienna}, country={Austria}, year={2012}, pages={307-308} }